Eisai Innovation, Inc. — Full Portfolio

Sift Biosciences develops T-cell immunotherapies for cancer and autoimmune diseases, using an AI-driven discovery platform combined with metagenomics and high-throughput cellular screening to identify microbially derived molecules that activate memory T cells.

AI & Machine LearningBiotechHealthtechSan Carlos, US

YCYue Clare Lou(Co-Founder & CEO)in

BoardKBKevin Barrett(Director)inAltar Munis(Director)

Co-investorsSBSBI HoldingsFIFifty YearsFRFREEFLOWLILifespan Vision Ventures

PRISM BioLab is a biotechnology company that develops PepMetics, a proprietary drug discovery platform of small molecules designed to mimic α-helix or β-turn peptides, aiming to target proteins previously considered "undruggable." The company maintains a screening library of over 20,000 compounds and partners with pharmaceutical firms on drug discovery programs.

AI & Machine LearningBiotechDeep TechTokyo, JP

Co-investorsDBDBJ CapitalNENewton Biocapital

Altoida builds a multi-modal Digital NeuroMarker Platform that combines augmented reality, sensor fusion, and explainable AI in a 10-minute self-administered assessment to detect early signs of Mild Cognitive Impairment and Alzheimer's disease.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsALAlpana VenturesDADaniel GutenbergHIHikma VenturesM M VenturesPOPolytech Ecosystem VenturesVIVI Partners+3 more

Arteryex combines blockchain and AI technology to leverage underutilized health data for personalized healthcare management and medical services.

AI & Machine LearningDigital HealthHealthtechWellness & Fitness

李 東瀛 (Dongying Li)(代表取締役 (CEO))東 太輝 (Taiki Higashi)(取締役副社長 / 最高財務責任者 (CFO))里見 健太 (Kenta Satomi)(最高技術責任者 / エンジニア育成責任者 (CTO))小野澤 侑 (Yu Onozawa)(最高執行責任者 / データビジネス事業部長 (COO))

Beren is a public benefit corporation developing novel medicines in partnership with patients, caregivers, clinicians, and health systems.

BiotechHealthtech

JCJason Camm(Founder, President & Chief Executive Officer)inAOAaron Ondrey(Chief Financial Officer)inAGAlex Gold(Chief Medical Officer)inJSJennifer Spinella(Chief Regulatory Officer & Head of Quality)inIVIrene von Hennigs(SVP, Global Medical Affairs)inBSBennett Smith(SVP, Commercial)in

Co-investorsALAlpha Wave GlobalNANarya CapitalOCOctave Ventures LlcUTUTokyo Innovation Platform Co. Ltd.

Bliss BioPharma is a biopharmaceutical company focused on the CMC development and commercialization of biologics, including therapeutic monoclonal antibodies, bispecific antibodies, ADCs, recombinant proteins, and vaccines.

BiotechHealthtech

Caraway Therapeutics was a preclinical biopharmaceutical company developing small-molecule therapies modulating lysosomal function to treat neurodegenerative and rare diseases.

BiotechHealthtech

Co-investorsDEDementia Discovery FundMCMcCarthy CapitalMRMRL Ventures FundSVSV Health InvestorsABAbbVieBRBridge Investments+9 more

Casma is a biotech company developing technology that uses the autophagy pathway to degrade disease targets for therapeutic applications.

BiotechDeep TechHealthtechBoston, US

ABAndrea Ballabio(Founder)BLBeth Levine(Founder)Herbert Virgin(Founder)JHJames Hurley(Founder)in

Co-investorsASAstellas Venture Management LLCTHThird Rock VenturesONOno Venture Investment, Inc.THThe Column Group

Cogstate provides digital cognitive assessments, electronic clinical outcome assessment (eCOA) support, and endpoint data quality services for biopharmaceutical companies, academic institutions, and clinicians.

BiotechDigital HealthHealthtechMedical DevicesMelbourne, AU

BOBrad O'Connor(Chief Executive Officer)inDr. Ventola(Chief Science Officer)

Co-investorsDODolby Family Ventures

Darmiyan develops medical AI and brain imaging software for early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

PKPadideh Kamali-Zare(CEO)inKVKaveh Vejdani(Chief Medical and Technology Officer)inThomas Liebmann(Chief Scientific Officer)

BoardShirai Takehiro(Director)

Co-investorsAAAAF Management Ltd.ITIT-Farm CorporationSOSoma CapitalY Y CombinatorARArkitekt VenturesBABaleen Capital+7 more

eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.

BiotechDeep TechMedical Devices

MCMike Curtis, Ph.D.(President & Chief Executive Officer)George M. Church(Founder)Luhan Yang(Founder)

Co-investorsALAlta PartnersALAltium CapitalFRFresenius Medical Care VenturesKHKhosla VenturesLULux CapitalARARCH Venture Partners

Eisai is a global research-based pharmaceutical company focused on neurology and oncology, with a commitment to patient-centric healthcare solutions worldwide.

BiotechHealthtechMedical Devices

Iambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors.

AI & Machine LearningBiotechDeep TechSan Diego, US

TMTom Miller(Founder)inFred Manby(Founder)inCZChao Zhang(Executive Officer)inTabbert Teng(Executive Officer)NJNeil Josephson(Chief Medical Officer)inPOPete Olson(Chief Scientific Officer)in

Co-investorsASAscenta CapitalABAbingworthCACatalio Capital ManagementALAlumni VenturesCACatalio Capital Management, LPCOCoatue Management+7 more

Neuroglee provides remote dementia and memory care through a care team of navigators, clinicians, social workers, and pharmacists who coordinate treatment, offer 24/7 support, and connect patients and caregivers with community resources.

Digital HealthHealthtechLongevity

ASAniket Singh Rajput(Founder)in

Co-investorsOPOpenspace Ventures

Numab develops multispecific antibody-based therapeutics using its proprietary λ-Cap and MATCH discovery and engineering platforms, aiming to improve on first-generation antibody therapies in potency, stability, effect duration, and safety.

BiotechDeep Tech

DUDavid Urech(Founder)in

Co-investorsHBHBM Healthcare InvestmentsHBHBM PartnersBIBiotechnology Value FundBLBlackRockFOForbionNONovo Holdings+1 more

Ophidion is a biotechnology company developing therapeutics based on the cholinergic system and lynx gene modulators, which regulate nicotinic acetylcholine receptors.

BiotechDeep TechHealthtechMedical DevicesBethlehem, US

JMJulie Miwa(Founder)inYacoub Habib(CEO & Chairman of the Board)Brigitte Angenieux(Executive Director of Preclinical Research)Rajika Perera(Head of Peptide and Protein Discovery & Development)

BoardMichael Lark(Director)Scott Fishman(Director)

Co-investorsDEDelaware Crossing Investor GroupGAGaingelsRORobin Hood Ventures

Oura Ring is a wearable smart ring that collects and analyzes 50+ personal health metrics to provide insights on sleep, fitness, and wellness for individual users.

HardwareHealthtechWellness & FitnessSan Francisco, US

Ashley Colley(Founder)Virpi Tuomivaara(Founder)inTHTom Hale(Chief Executive Officer)inKari Kivela(Founder)Markku Koskela(Founder)Petteri Lahtela(Founder)

Co-investors12125 VenturesA-A-Rod CorpABAble PartnersALAlumni VenturesB3B37 VenturesBABasecamp Fund+38 more

Periotherapia develops antibody-based therapeutics targeting pathological periostin in the stromal environment to treat refractory diseases including cancer, diabetic retinopathy, and heart disease.

BiotechDeep TechDigital HealthHealthtechMedical DevicesOsaka, JP

YTYoshiaki Taniyama(Director and Founder)Eiji Tahara(Representative Director, President, CEO and COO)

Co-investorsCHChishima Real Estate — Startup Investment

ProTgen is a clinical-stage biotechnology company developing targeted Notch activators that generate progenitor T cells to restore thymic function and adaptive immune competence.

BiotechHealthtechToronto

Juan Carlos Zuniga-Pflucker(Executive Officer, Director)

BoardFei Shen(Director)Ferdinand Massari(Director)

Co-investorsFAFACIT (Fight Against Cancer Innovation Trust)BOBoehringer Ingelheim Venture Fund

Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSuzhou, CN

DLDr. Long-Cheng Li(CEO and Founder)Dr. Moorim Kang(Chief Technology Officer)

Co-investorsSDSDIC Venture Capital

SEED Therapeutics develops de novo molecular glue degraders for targeted protein degradation, using its RITE3 platform to match E3 ligases with disease-causing target proteins.

BiotechDeep TechHealthtechKing of Prussia, US

LHLan Huang(Ph.D.)inAvram Hershko, M.D.(Co-Founder)Lan Huang, Ph.D.(Co-Founder, CEO and Chairman)NZNing Zheng, Ph.D.(Co-Founder)Michele Pagano, M.D.(Co-Founder)

SOLA Biosciences is a preclinical-stage biopharmaceutical company developing gene therapies for neurodegenerative diseases like ALS, Huntington's Disease, and Alzheimer's Disease by targeting misfolded proteins.

BiotechDeep TechMedical DevicesBoston, US

KKKeizo Koya(Founder and CEO)inAHAkinori Hishiya(Founder and CSF)in

Co-investorsMCMC Healthcare VenturesUTUTEC

Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes.

BiotechDeep TechHealthtechSan Francisco, US

Co-investorsCICivilization Ventures Management, LlcLALaurier Startup FundMIMitsui Global InvestmentKDKdT VenturesMIMichigan Capital Network

Unlearn develops AI-powered digital twins and data analytics tools to optimize clinical trial design and execution for pharmaceutical companies.

AI & Machine LearningBiotechDeep TechEnterprise SoftwareSan Francisco, US

CFCharles Fisher(Founder)inASAaron Smith(Founder)inJonathan Walsh(Founder)John Hamer(Director)Francisco Gimenez(Director)

Co-investors8V8VCALAlumni VenturesBABasecamp FundDCDCVC (Data Collective)FLFlucas VenturesINInsight Partners+6 more

Aptar Digital Health is a division of Aptar Pharma that designs and manufactures drug delivery systems and digital health solutions for the pharmaceutical and healthcare industries.

Digital HealthHealthtechMedical DevicesSaaS

Co-investorsCACapDecisif ManagementKAKaristaSASanofi VenturesVEVesalius Biocapital Partners

Allm uses information and communication technology to address healthcare disparities and mismatches, aiming to provide equitable medical and welfare services to all people.

AI & Machine LearningDigital HealthHealthtechMedical DevicesSaaS

Co-investorsASAsia Africa Investment & Consulting (AAIC)FAFast Track Initiative